discontinued

DDX0180P-50 CLEC4A antibody

See related secondary antibodies

Search for all "CLEC4A"

Quick Overview

Mouse anti Human CLEC4A 111F8.04

DDX0180P-50

More Views

  • DDX0180P-50
  • DDX0180P-50
  • DDX0180P-50
  • DDX0180P-50

Product Description for CLEC4A

Mouse anti Human CLEC4A 111F8.04.
Presentation: Purified
Product is tested for Immunoprecipitation, Frozen Sections, Western blot / Immunoblot, Flow Cytometry.

Properties for CLEC4A

Product Category Primary Antibodies
Quantity 50 µg
Synonyms C-type lectin DDB27, C-type lectin domain family 4 member A, C-type lectin superfamily member 6, CLECSF6, DCIR, Dendritic cell immunoreceptor, HDCGC13P, LLIR, Lectin-like immunoreceptor
Presentation Purified
Reactivity Hu
Applications C, F, IP, WB
Clonality Monoclonal
Clone 111F8.04
Host Mouse
Isotype IgG1
Shipping to Germany, USA/Canada
PDF datasheet View Datasheet
Manufacturer Dendritics SAS

Datasheet Extract

Immunogen
Swiss Prot Num:
Q9UMR7
Immunogen:
human DCIR-Ig fusion protein.
GeneID:
50856
Isotype control AM03095PU-N, SM10P (for use in human samples)
Application DDX0180P-50 / DDX0180P-100 Purified: FACS surface, ImmunoHistoChemistry frozen sections, Western Blot, Immunoprecipitation. 
DDX0180A488-50 / DDX0180A488-100 Alexa-fluor®488:  
FACS surface, ImmunoFluorescence, ImmunoHistoChemistry frozen sections, Western Blot.
DDX0180A546-50 / DDX0180A546-100 Alexa-fluor®546:
 ImmunoFluorescence, Western Blot. 
DDX0180A647-50 / DDX0180A647-100 Alexa-fluor®647:
FACS surface, Western Blot.
DDX0180B-50 / DDX0180B-100 Biotin: 
 ImmunoHistoChemistry frozen sections, Western Blot.
*This monoclonal antibody may be used between 5-20 μg/ml.
Background DCIR (dendritic cell immunoreceptor), also known as LLIR, DDB27, CLECSF6, HDCGC13P, is a member of the Dectin-2 family of C-type lectins. DCIR is expressed as a type II membrane glycoprotein of 237 aa with a single carbohydrate recognition domain (CRD), closest in homology to those of the macrophage lectin and hepatic asialoglycoprotein receptors. In contrast to the other members of this family, the intracellular domain of DCIR contains a consensus immunoreceptor tyrosine-based inhibitory motif (ITIM). DCIR is expressed on dendritic cells, monocytes, macrophages, B lymphocytes, neutrophils, granulocytes and plasmacytoid dendritic cells, but not detected on NK and T cells. In vitro, DCIR is strongly expressed by DCs derived from blood monocytes cultured with GM-CSF and IL-4 with a higher expression in CD14+ than CD1a+ derived DC. Finally, DCIR expression is down-regulated by signals inducing DC maturation such as CD40 ligand, LPS, or TNF-. Thus, DCIR is differentially expressed on DCs depending on their origin and stage of maturation/activation. DCIR represents a novel surface molecule expressed by antigenpresenting cells, and of potential importance in regulation of DC function.
(Bates EE et al, 1999; J. Immunol., 163: 1973-1983).
Product Citations
Originator or purchased from resellers:
  1. Bates EE, Fournier N, Garcia E, Valladeau J, Durand I, Pin JJ, et al. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol. 1999 Aug 15;163(4):1973-83. PubMed PMID: 10438934.
  2. Bloem K, Vuist IM, van der Plas AJ, Knippels LM, Garssen J, García-Vallejo JJ, et al. Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain. PLoS One. 2013 Jun 11;8(6):e66266. doi: 10.1371/journal.pone.0066266. Print 2013. PubMed PMID: 23776650. (Free PMC Article available, 5 images available)
  3. Bloem K, García-Vallejo JJ, Vuist IM, Cobb BA, van Vliet SJ, van Kooyk Y. Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells. Front Immunol. 2013 May 6;4:103. doi: 10.3389/fimmu.2013.00103. eCollection 2013. PubMed PMID: 23653626. (Free PMC Article available, 3 images available)
  4. Bloem K, thesis, 2013
  5. Tel J, Sittig SP, Blom RA, Cruz LJ, Schreibelt G, Figdor CG, et al. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion. J Immunol. 2013 Nov 15;191(10):5005-12. doi: 10.4049/jimmunol.1300787. Epub 2013 Oct 14. PubMed PMID: 24127556.
  6. Tjomsland V, Spångeus A, Sandström P, Borch K, Messmer D, Larsson M. Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor. PLoS One. 2010 Oct 15;5(10):e13441. doi: 10.1371/journal.pone.0013441. PubMed PMID: 20976171. (Free PMC Article available, 11 images available)
Storage -20°C. KEEP CONTENTS STERILE: no preservative.
Purified antibodies: avoid repeated freeze/thaw cycles.
Coupled antibodies: glycerol protects from freezing.
Format
Purification:
QMA Hyper D ion exchange chromatography
Buffer System:
100 μg in 200μl / 50 μg in 100 μl Tris-NaCl pH 8
State:
Purified
Specificity
Specificity:
human DCIR.
Gene ID 50856

Accessory Products

Proteins and/or Positive Controls

Proteins for CLEC4A (2 products)

Catalog No. Species Pres. Purity   Source  

CLEC4A

CLEC4A Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
  Abnova Taiwan Corp.

CLEC4A

CLEC4A Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
  Abnova Taiwan Corp.

Positive controls for CLEC4A (4 products)

Catalog No. Species Pres. Purity   Source  

CLEC4A 293T Cell Transient Overexpression Lysate(Denatured)

CLEC4A 293T Cell Transient Overexpression Lysate(Denatured)
  Abnova Taiwan Corp.

CLEC4A overexpression lysate

CLEC4A overexpression lysate
0.1 mg / €295.00
  OriGene Technologies, Inc.

CLEC4A overexpression lysate

CLEC4A overexpression lysate
0.1 mg / €295.00
  OriGene Technologies, Inc.

CLEC4A overexpression lysate

CLEC4A overexpression lysate
0.1 mg / €315.00
  OriGene Technologies, Inc.
  • LinkedIn